• 1.
    Fleckenstein A. History of calcium antagonists. Circ Res. 1983; 52(2 pt 2):I3I16.
  • 2.
    Conti CR. Calcium antagonists are here to stay, in my opinion. Clin Cardiol. 1996;19:529530.
  • 3.
    Mullins ME, Horowitz BZ, Linden DHJ, et al. Life-threatening interaction of mibefradil and beta blockers with dihydropyridine calcium channel blockers. JAMA. 1998;280:157158.
  • 4.
    Kukovetz WR, Holzmann S, Pöch G. Molecular mechanism of action of nicorandil. J Cardiovasc Pharmacol. 1992;20(suppl 3):S1S7.
  • 5.
    Fernández-Avilés F. Ivabradine and comprehensive treatment of CAD: Proceedings of a Satellite Symposium held during the European Society of Cardiology Congress. Stockholm, Sweden. 30 August 2010. Eur Heart J Suppl. 2010;12(suppl C):C16C20.
  • 6.
    Sulfi S, Timmis AD Ivabradine—the first selective sinus node If channel inhibitor in the treatment of stable angina. Int J Clin Pract. 2006;60:222228.
  • 7.
    Belardinelli L, Shryock JC, Fraser H. Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart. 2006;92:iv6iv14.